Managing Director and Academic Lead, Dr Mikael Sodergren, contributes to Elisabeth Mahase’s feature in this week’s bmj ‘Medical Cannabis: patients turn to private clinics because of NHS void’.
We aim to make things easy and to keep you informed of your progress every step of the way, from the moment you apply to the receipt of your prescription(s).
Managing Director and Academic Lead, Dr Mikael Sodergren, contributes to Elisabeth Mahase’s feature in this week’s bmj ‘Medical Cannabis: patients turn to private clinics because of NHS void’.
Medical Cannabis and Autism Spectrum Disorder: Latest Findings from the UK Medical Cannabis Registry Autism affects around 1 ...
Cannabidiol (CBD) is available in many consumer products and is also the subject of extensive medical and scientific ...
Opioids are among the most commonly prescribed medicines for pain. Yet there is a puzzle at the heart ...
Restless leg syndrome is more common than many people realise. Research suggests it affects roughly 7 to 12 ...
Paracetamol, also known as acetaminophen, is one of the most widely used painkillers in the world. Yet despite ...
Most mental health conditions start earlier in life than many people expect. A large international study found that ...
A laboratory study in mice reports that activating cannabinoid type 1 (CB1) receptors reduced sweating. Researchers suggest the ...
The human body makes its own cannabis-like chemicals. Known as endocannabinoids, these natural molecules act as messengers in ...
A recent randomised controlled trial, published in eClinicalMedicine, aimed to investigate the effect of a high oral dose ...